Discover 3,132 paid clinical trials in Houston, Texas. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Houston is home to world-renowned medical centers offering a variety of trials targeting conditions such as cancer, heart disease, diabetes, and Alzheimer’s. Healthy volunteers interested in paid research opportunities, as well as individuals in need of trials for specific conditions, can participate in these studies to access cutting-edge treatments and contribute to the development of innovative therapies.
Filter
2
Filter results
Results: 3,132
IO vs IV Vancomycin in Tourniquetless TKA
for
Infection, Surgical Site
Location: Houston TX
Sponsor: The Methodist Hospital Research Institute
Sex: All
Age: 19 - 70+
Code: NCT05705843
Recruiting
Project Health Intervention Among Latinx Adults in Primary Care
for
Obesity
Location: Houston TX
Sponsor: University of Houston
Sex: All
Age: 18 - 25
Code: NCT04090515
Recruiting
University of Houston Drug Abuse Research Development Program II
A Mobile Intervention for Black Individuals Who Engage in Hazardous Drinking
for
Alcohol Abuse, Anxiety
Location: Houston TX
Sponsor: University of Houston
Sex: All
Age: 21+
Code: NCT06416059
Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Mobile App for Latinx Hazardous Drinkers With Clinical Anxiety
for
Alcohol Abuse, Anxiety
Location: Houston TX
Sponsor: Michael J. Zvolensky, Ph.D.
Sex: All
Age: 21+
Code: NCT05288699
Recruiting
Fulvestrant+Abemaciclib With Run-In of Fulvestrant in Er-Positive, Her2-Negative Metastatic Breast Cancer
for
ER-Positive Breast Cancer, HER2-negative Breast Cancer
Location: Houston TX
Sponsor: The Methodist Hospital Research Institute
Sex: All
Age: 18+
Code: NCT05305924
Phase 2, Recruiting
Converting HR+ Breast Cancer Into an Individualized Vaccine
for
Breast Cancer
Location: Houston TX, Dallas TX, New York NY
Sponsor: Weill Medical College of Cornell University
Sex: Female
Age: 18 - 70+
Code: NCT03804944
Phase 2, Recruiting
A Study to Evaluate the Effectiveness and Safety of Setidegrasib, Given With Either mFOLFIRINOX or NALIRIFOX Chemotherapies, in People With Pancreatic Cancer
for
Pancreatic Cancer, Metastatic Pancreatic Cancer,
Location: Houston TX, Dallas TX, Fort Smith AR, Oklahoma City OK,
Sponsor: Astellas Pharma Global Development, Inc.
Sex: All
Age: 18+
Code: NCT07409272
Phase 3, Recruiting
A Study of Ifinatamab Deruxtecan Versus Treatment of Physician's Choice in Subjects With Relapsed Small Cell Lung Cancer
A Clinical Study of Gocatamig (MK-6070) and Infinatamab Deruxtecan (MK-2400) in People With Small Cell Lung Cancer (MK-6070-003)
for
Small Cell Lung Cancer Extensive Stage
Location: Houston TX, Memphis TN, Nashville TN, St Louis MO,
Sponsor: Merck Sharp & Dohme LLC
Sex: All
Age: 18+
Code: NCT07227597
Phase 1, Phase 2, Recruiting
Study of RP2 in Combination With Second-line Therapy in Patients With Locally Advanced or Metastatic HCC
for
Hepatocellular Carcinoma, Biliary Tract Cancer
Location: Houston TX, Germantown TN, Knoxville TN, Tampa FL,
Sponsor: Replimune Inc.
Sex: All
Age: 18+
Code: NCT05733598
Phase 2, Recruiting
A Prospective Registry Study to Assess Real-world Patient Characteristics, Treatment Patterns, and Longitudinal Outcomes in Patients Receiving Mavacamten and Other Treatments for Symptomatic Obstructive Hypertrophic Cardiomyopathy (Obstructive-HCM)
for
Obstructive Hypertrophic Cardiomyopathy
Location: Houston TX, Temple TX, Dallas TX, Plano TX,
Sponsor: Bristol-Myers Squibb
Sex: All
Age: 18+
Code: NCT05489705
Recruiting
A Study to Evaluate Zilovertamab Vedotin (MK-2140) Combination With Rituximab Plus Cyclophosphamide, Doxorubicin, and Prednisone (R-CHP) Versus Rituximab Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone (R-CHOP) in Participants With Previously Untreated DLBCL (MK-2140-010)
for
Diffuse Large B-Cell Lymphoma
Location: Houston TX, The Woodlands TX, Alexandria LA, Dallas TX,
Sponsor: Merck Sharp & Dohme LLC
Sex: All
Age: 18+
Code: NCT06717347
Phase 3, Recruiting
MagnetisMM-32: A Study to Learn About the Study Medicine Called Elranatamab in People With Multiple Myeloma (MM) That Has Come Back After Taking Other Treatments (Including Prior Treatment With an Anti-CD38 Antibody and Lenalidomide)
for
Multiple Myeloma
Location: Houston TX, Sugar Land TX, The Woodlands TX, Temple TX,
Sponsor: Pfizer
Sex: All
Age: 18+
Code: NCT06152575
Phase 3, Recruiting
Mobile Smoking Treatment for Spanish-speaking Latinx Smokers
for
Smoking Cessation
Location: Houston TX
Sponsor: University of Houston
Sex: All
Age: 18 - 55
Code: NCT04417075
Recruiting
Shaping Habitual Impulses For a Tobacco-free Style
for
ST+ABR, ST+SHAM, ST-only
Location: Houston TX
Sponsor: University of Houston
Sex: All
Age: 18+
Code: NCT07025772
Recruiting
Trifecta-Lung cfDNA-MMDx Study
for
Lung Transplantation
Location: Houston TX, San Antonio TX, Dallas TX, Gainesville FL,
Sponsor: University of Alberta
Sex: All
Age: 18+
Code: NCT05837663
Recruiting
Want a closer look at research in Houston? Read our guide: Clinical Trials in Houston: Why the City Leads the Country